BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 31187175)

  • 1. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
    Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
    J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer.
    Chen X; Chen F; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
    Prostate; 2019 Sep; 79(12):1386-1398. PubMed ID: 31334877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
    Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
    Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
    Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
    J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.
    Szmulewitz RZ; Chung E; Al-Ahmadie H; Daniel S; Kocherginsky M; Razmaria A; Zagaja GP; Brendler CB; Stadler WM; Conzen SD
    Prostate; 2012 Feb; 72(2):157-64. PubMed ID: 21563193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop between Wnt/β-catenin signaling and hTERT regulates the cancer stem cell-like traits in radioresistant nasopharyngeal carcinoma cells.
    Chen K; Chen L; Li L; Qu S; Yu B; Sun Y; Wan F; Chen X; Liang R; Zhu X
    J Cell Biochem; 2020 Nov; 121(11):4612-4622. PubMed ID: 32065421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.
    Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK
    Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J; Wu S; Wu H; Li L; Guo T
    Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.
    Wang B; Liu J; Ma LN; Xiao HL; Wang YZ; Li Y; Wang Z; Fan L; Lan C; Yang M; Hu L; Wei Y; Bian XW; Chen D; Wang J
    J Gastroenterol; 2013 Jul; 48(7):798-808. PubMed ID: 23188090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44
    Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J
    Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen reduces cell proliferation through inhibiting Wnt/β catenin signaling pathway in gastric cancer stem cells.
    Akrami H; Moradi B; Borzabadi Farahani D; Mehdizadeh K
    Cell Biol Int; 2018 Aug; 42(8):949-958. PubMed ID: 29512256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.
    Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y
    Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Accumulation of β-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Tanaka H; Kawaguchi M; Shoda S; Miyoshi T; Iwasaki R; Hyodo F; Mori T; Hara A; Tomita H; Matsuo M
    Anticancer Res; 2019 Dec; 39(12):6575-6583. PubMed ID: 31810923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.